Side-by-side financials for CTKB and A. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CTKB | A |
|---|---|---|
| Market cap | - | $36.61 B |
| US-listed rank | - | #411 |
| Revenue (latest FY) | $201.49M | $6.95B |
| Net income (latest FY) | -$66.54M | $1.30B |
| Net margin | -33.0% | 18.8% |
| P/E (trailing FY) | - | 28.1 |
| SEC filings | 432 | 2,339 |
In their latest fiscal years, Cytek Biosciences, Inc. reported $201.49M in revenue while AGILENT TECHNOLOGIES, INC. reported $6.95B.
Full pages: Cytek Biosciences, Inc. and AGILENT TECHNOLOGIES, INC., or browse the full rankings.